PHASE 14 · 4-SKU COMPARISON AUDIT · 21 · NICHE-LAUNCH-RESEARCH SKILL · FIRST USE-CASE
First use-case of the new niche-launch-research skill. Probe the existing MiroFish OASIS sim (108 agents · 565 actions) for women specifically aged 45-60 (perimenopause through early menopause). Two questions fired: pain-point ranking + 4-SKU fit-grade + biggest-gap SKU. Verbatim sim quotes inline.
Our existing ICP (artefact 03) spans Sarah 35-42 + Jane 42-52 + Mei 52-62. The 45-60 band sits in Jane's upper half + Mei's lower half — peri-meno transition + early post-meno. Two MiroFish queries probed (a) what hurts most in 45-60 specifically, and (b) which of our 4 SKUs covers each pain. Verdict: 4/4 SKUs partially cover but bone+joint health is the structural gap. A 5th SKU (working title: FORTIFY) at $44-49 closes it.
The sim's insight_forge tool surfaced explicit PIVOT-cohort signal for the top 3. The 4-10 bracket was inferred (low direct-quote density) — flag as "needs WH scrape verification" when MCP reconnects.
Quote evidence (top 3): "PIVOT Menopause Symptom Stack is targeted at Jane 42-52 for joint pain, hot flash, and libido drop." — single sim-graph triple covers ranks 1+2+3, but PIVOT only leads with hot-flash + libido in its current advertorial framing. Joint pain is a secondary mention, not a hero claim.
Best fit for 45-60. Directly named in sim graph for joint pain + hot flash + libido drop — the exact top-3 pain-points for this cohort. The cohort overlaps with Jane (42-52 in our ICP) and lower-Mei (52-62).
Caveat: Doctrine 7 PIVOT OB/GYN gate must clear before any spend (artefact 09). Hard-block without Dr Haver-style cosign.
Strong fit for upper-half (52-60). Patricia Wong (52yo · post-meno · ISTJ) is the named direct-buyer in the sim — and her Dr Mary Claire Haver 18-year OB/GYN relationship is the unlock (artefact 20). Top-LTV cohort lives here.
Caveat: Patricia needs 500+ Trustpilot reviews before scale (artefact 15 risk forecast). Month-3 launch per artefact 16 Phase 2.
Cross-bracket fit, primary 35-44. Sim explicitly anchors CALM to "Sarah 35-42 active mom" — younger cohort. For 45-60, CALM serves the cortisol + sleep angle but loses to brand-specific peri-stress positioning (Naali archetype). $34 magnet price works cross-bracket as bundle BOFU.
Strategy: use CALM as bundle attach to PIVOT in 45-60 targeting. Don't lead with CALM alone for this cohort.
Lower fit for 45-60 specifically. REVIVE's primary angle is GLP-1 induced hair loss (Mounjaro/Ozempic) — strongest signal in Sarah 35-42 + Brittany cohorts. For 45-60, peri-shed is real but less GLP-1-driven; estrogen-decline framing competes harder with Nutrafol.
Reposition lever: Build a 45-60-specific REVIVE variant or REVIVE+PIVOT bundle framing — "peri hair + meno mood" combo. Saves needing a 5th hair-only SKU.
GAP SKU · GREENLIGHT FOR MONTH-6 RESEARCH
The structural gap is bone density + joint support combo. The MiroFish sim direct quote: "Introducing a bone health SKU would cater to an unaddressed pain-point in this demographic." Joint pain ranked #3 in 45-60 pain hierarchy with ZERO dedicated SKU coverage. Bone density loss ranks #7 with zero coverage either. Combine them — Ca + D3 + K2 + magnesium glycinate + collagen Type II — into a single FORTIFY SKU and you cover ranks 3 AND 7 in one bottle.
Why this beats spinning a generic 5th SKU: bone+joint is the ONLY pain-pair that (a) ranks in top 10, (b) has zero of our 4 SKUs covering it, (c) cross-references the artefact 01 whitespace map (Doctrine 5 #3 + #4 — bone density 40+ + circulation/cellulite). Three signals converging is the threshold.
Before adding a 5th SKU (~$20K SKU dev + ~$25K first-batch inventory + ~$30K month-1 ad spend = ~$75K commit), test whether existing 4 SKUs can re-cover the 45-60 gap via 3 cheaper plays.
| Option | What changes | Cost | Verdict |
|---|---|---|---|
| A · Reposition PIVOT as joint-pain hero (not menopause-balance) | Rewrite advertorials A19+A20 in artefact 12 to lead with joint-pain (rank #3) over hot-flash (rank #1). Hot-flash becomes secondary. | $200 (rewrite + retest) | Risky — splits PIVOT brand identity. Joint pain isn't the meno hero claim. SKIP. |
| B · REVIVE+PIVOT bundle for 45-60 cohort | Create a "peri+meno combo" bundle at $89 (saves $9 vs separate). Adds 1 PDP + 1 ad set. | $0 (no inventory · uses existing) | YES · do this first. Cheap test of whether bundle revenue + cohort engagement justifies a real 5th SKU. |
| C · Extend BLOOM to include calcium | Reformulate BLOOM v2 with calcium + D3 added. Same SKU repositioning as "vaginal + bone." | $8K reformulation | NO. Confuses BLOOM's vaginal-probiotic positioning. Dilutes Patricia trust. |
| D · Build FORTIFY (new 5th SKU) | Full Day-14 → Day-0 execution kit replica (artefact 18 pattern). $75K total commit. | $75K | ONLY after Option B bundle proves demand. Phase-6 (Month 6+) decision. |
Recommended sequence: launch Options A/D never. Fire Option B (bundle test) at Day 10 of the soft-run (after REVIVE clears Day-7 gate). If bundle attach-rate ≥ 22% on 45-60 segments, greenlight FORTIFY for Month 6 research + Month 8 launch.
| Update | Target | Owner |
|---|---|---|
| Add 45-60 cohort segmentation to artefact 03 ICP catalog. Currently 35-42 / 42-52 / 52-62. Split Jane 42-52 into Jane-younger (42-47) + Jane-older (47-52). | artefact 03 | creative-director |
| Rewrite PIVOT advertorials A19+A20 to add joint-pain to hero stack (currently hot-flash+libido). Make it "the 3 things menopause takes." | artefact 12 + 18 (REVIVE Kit pattern → PIVOT kit) | creative-director |
| Bundle test (Option B) "REVIVE+PIVOT peri+meno combo" at $89 · Day 10 fire | artefact 13 launch week (add Day 10 bundle test) + artefact 14 audience H4 (new bundle audience) | marketing |
| FORTIFY Month-6 research slot added to artefact 16 Phase 4 (was bust-gummy from 19 + bone-gummy can run parallel) | artefact 16 Phase 4 | researcher |
| Doctrine 8 (new): No 5th SKU spend until 4-SKU bundle-attach test runs ≥21 days. Same gate-discipline as Doctrine 6. | artefact 09 doctrines | Jenn approval |
This artefact is the FIRST output of the new niche-launch-research skill. The skill scaffolding (SKILL.md + HOOKS.md + PIPELINE.md + fire.sh + 3 sub-skill scripts + hub builder + shared CSS) was authored in this session at ~/.zennith/skills/niche-launch-research/.
What this artefact proves: the skill can run as a focused single-artefact analysis (not just the full 20-chain). For comparison-against-existing-chain use-cases (like this 45-60 audit), the right entry is: fire.sh --artefact 21 after seeding state.json with the cohort definition + comparison target.
Next use-cases queued for niche-launch-research: (a) full chain for bust-firmness gummy (Felicia Adeyemi cohort · artefact 19 spawn), (b) full chain for DACH market (Hannah Schneider cohort · EFSA path), (c) full chain for K-beauty crossover SKU (Hannah Park · $69 Korean trial data tier).
ARTEFACT 21 · 4-SKU COMPARISON · GAP IDENTIFIED
PIVOT carries the most weight for 45-60 (hot-flash + libido + joint partial-cover). BLOOM owns upper-half (52+) via Patricia Wong + Dr Haver. CALM serves as bundle attach. REVIVE drops a tier because peri-shed framing competes harder with Nutrafol than GLP-1 shed framing did. Real structural gap is bone+joint. Sequenced answer: bundle test Day 10 → FORTIFY Month-6 research → Month-8 launch if bundle proves demand.